1 In the metastatic validation cohort, patients of any
age were eligible if they were enrolled at Mayo Clinic between Se
2 Children were eligible if they were aged 1-59 months at hospital disch
3 Children were eligible if they were aged 8 to 19 years at the time of
4 Children were eligible if they were born in a KPNC or contracting hosp
5 Their
children were eligible if they were younger than 5 years or were liveb
6 d as the catchment area of a single public health
facility,
were eligible if they were at least 15 km from Mwanza City an
7 Girls were eligible if they were aged 9-14 years, healthy, and HIV
8 Infants were eligible if they were 36 weeks' gestational age or older
9 Instruments were eligible if they were originally developed to measure th
10 Patients younger than 20 years with high-risk
neuroblastoma were eligible if they were diagnosed between 2000 and 2012 an
11 Patients with stage III
NSCLC were eligible if they were excluded from cisplatin-based prot
12 All adults, age 60 and
over,
were eligible if they were ambulatory and had a long-term his
13 Participants were eligible if they were 6-49 years of age with information
14 Participants were eligible if they were aged 18 years or older, and smoked
15 Participants were eligible if they were aged 18-60 years and had had treat
16 Participants were eligible if they were healthy adults, aged 18-50 years w
17 Patients were eligible if they were 40 to 80 years of age, had COPD (d
18 Patients were eligible if they were adults with HIV, who were naive to
19 Patients were eligible if they were age 18 to 70 years with primary cu
20 Patients were eligible if they were aged 0-17 years with 3 or more vis
21 Patients were eligible if they were aged 16 years or older, and had hi
22 Patients were eligible if they were aged 16 years or older; metastatic
23 Patients were eligible if they were aged 18 years or more and were new
24 Patients were eligible if they were aged 18 years or older (19 years o
25 Patients were eligible if they were aged 18 years or older and had an
26 Patients were eligible if they were aged 18 years or older, HIV positi
27 Patients were eligible if they were aged 18-80 years, had Parkinson's
28 Patients were eligible if they were aged 21 years or older, in New Yor
29 Patients were eligible if they were aged 21-70 years, diagnosed with t
30 Patients were eligible if they were aged 50 years or older, had been t
31 Patients were eligible if they were asymptomatic (score of 0 or 1 on i
32 Patients were eligible if they were at least 12 years old with cystic
33 Patients were eligible if they were at least aged 18 years, had Easter
34 Patients were eligible if they were older than 16 years, had evidence
35 Patients were eligible if they were older than 18 years, able to give
36 Patients were eligible if they were older than 18 years, had a confirm
37 Patients were eligible if they were previously untreated and human imm
38 Patients were eligible if they were: >/=18 years old; at risk of press
39 education to be representative of the UK adult
population)
were eligible if they were a current UK resident, aged 18 yea
40 Patients with recurrent or incurable
SCCHN were eligible if they were chemotherapy naive or if they had
41 Patients in 12 ambulatory care
settings were eligible if they were age >40 years and if they had Kell
42 Studies were eligible if they were original studies published in a pe
43 Studies were eligible if they were randomised controlled trials (RCTs
44 Studies were eligible if they were randomized controlled trials compa
45 Women were eligible if they were admitted to the participating heal
46 Women were eligible if they were married, 15-40 years of age, 17-34
47 Women were eligible if they were pregnant, had just tested HIV-posi
48 Iron-replete, nonanemic
women were eligible if they were uninfected with human immunodefici
49 Pregnant
women were eligible if they were aged 18-38 years, infected with HI
50 Children younger than 16
years were eligible if they were admitted or being prepared for adm